ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea
Case Medical Research
◽
10.31525/ct1-nct04036448
◽
2019
◽
Author(s):
Keyword(s):
Mantle Cell Lymphoma
◽
Myelodysplastic Syndromes
◽
Cell Lymphoma
◽
Interventional Study
◽
Mantle Cell
Download Full-text
Related Documents
Cited By
References
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
Croatian Medical Journal
◽
10.3325/cmj.2021.62.455-63
◽
2021
◽
Vol 62
(5)
◽
pp. 455-463
Author(s):
Sandra Bašić-Kinda
◽
Karla Mišura Jakobac
◽
Jasminka Sinčić-Petričević
◽
Dajana Deak
◽
Marijo Vodanović
◽
...
Keyword(s):
Mantle Cell Lymphoma
◽
Cell Lymphoma
◽
Real Life
◽
Cooperative Group
◽
Interventional Study
◽
Hematologic Diseases
◽
Mantle Cell
Download Full-text
PS1265 IMPROVEMENTS IN OUTCOME OF MANTLE-CELL LYMPHOMA (MCL) ARE MOSTLY DUE TO ADVANCES IN INDUCTION THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) – A REAL-LIFE NON-INTERVENTIONAL STUDY OF KROHEM
HemaSphere
◽
10.1097/01.hs9.0000563340.44346.69
◽
2019
◽
Vol 3
(S1)
◽
pp. 579
Author(s):
I. Aurer
◽
K. Misura-Jakobac
◽
J. Sincic-Petricevic
◽
D. Deak
◽
M. Vodanovic
◽
...
Keyword(s):
Stem Cell
◽
Stem Cell Transplantation
◽
Mantle Cell Lymphoma
◽
Cell Transplantation
◽
Autologous Stem Cell Transplantation
◽
Induction Therapy
◽
Cell Lymphoma
◽
Real Life
◽
Interventional Study
◽
Mantle Cell
Download Full-text
Decision letter for "Radiotherapy in mantle cell lymphoma: a literature review"
10.1002/hon.2708/v2/decision1
◽
2019
◽
Keyword(s):
Literature Review
◽
Mantle Cell Lymphoma
◽
Cell Lymphoma
◽
Mantle Cell
Download Full-text
Mantle Cell Lymphoma Rising in Association with Inverted Papilloma
10.1055/s-0039-1679844
◽
2019
◽
Author(s):
Charles Tong
◽
Peter Papagiannopoulos
◽
Michael Feldman
◽
Nithin Adappa
◽
James Palmer
Keyword(s):
Mantle Cell Lymphoma
◽
Cell Lymphoma
◽
Inverted Papilloma
◽
Mantle Cell
Download Full-text
Mantle Cell Lymphoma Presenting with Unusual Morphology in an Adolescent Female: A Case Report and Review of the Literature
Pediatric and Developmental Pathology
◽
10.2350/06-08-0142
◽
2006
◽
Vol preprint
(2007)
◽
pp. 1
Author(s):
Kristi Smock
◽
Hassan Yaish
◽
Mitchell Cairo
◽
Mark Lones
◽
Carlynn Willmore-Payne
◽
...
Keyword(s):
Case Report
◽
Mantle Cell Lymphoma
◽
Cell Lymphoma
◽
Adolescent Female
◽
Review Of The Literature
◽
Mantle Cell
Download Full-text
FDA grants accelerated approval to zanubrutinib for mantle cell lymphoma
Case Medical Research
◽
10.31525/cmr-21d603c
◽
2019
◽
Author(s):
Keyword(s):
Mantle Cell Lymphoma
◽
Cell Lymphoma
◽
Mantle Cell
◽
Accelerated Approval
Download Full-text
A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma
Case Medical Research
◽
10.31525/ct1-nct03877055
◽
2019
◽
Author(s):
Keyword(s):
Mantle Cell Lymphoma
◽
Cell Lymphoma
◽
Mantle Cell
Download Full-text
Faculty Opinions recommendation of Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1248959.717057
◽
2009
◽
Author(s):
Michael Williams
Keyword(s):
Mantle Cell Lymphoma
◽
Phase Ii
◽
Phase Ii Study
◽
Cell Lymphoma
◽
Ibritumomab Tiuxetan
◽
Mantle Cell
◽
Yttrium 90
Download Full-text
Faculty Opinions recommendation of Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717297959.792752812
◽
2012
◽
Author(s):
Nicolas Mounier
Keyword(s):
Mantle Cell Lymphoma
◽
Minimal Residual Disease
◽
Feasibility Study
◽
Residual Disease
◽
Cell Lymphoma
◽
Disease Monitoring
◽
Lymphoid Malignancies
◽
Minimal Residual Disease Monitoring
◽
Mantle Cell
◽
Minimal Residual
Download Full-text
Faculty Opinions recommendation of Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90-ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group Study E1499.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717954686.793461217
◽
2012
◽
Author(s):
Nicolas Mounier
Keyword(s):
Mantle Cell Lymphoma
◽
Phase Ii
◽
Phase Ii Study
◽
Cell Lymphoma
◽
Eastern Cooperative Oncology Group
◽
Oncology Group
◽
Ibritumomab Tiuxetan
◽
Oncology Group Study
◽
Mantle Cell
◽
Yttrium 90
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close